Suzhou Novoprotein Scientific Co (SHSE:688137) Research & Development: ¥66.7 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688137 Suzhou Novoprotein Scientific Co Ltd SHSE:688137
62 GF Score
Price ¥34.76
GF Value ¥37.73
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Suzhou Novoprotein Scientific Co Research & Development?

Suzhou Novoprotein Scientific Co SHSE:688137 +1.67% 62 Research & Development is ¥66.7 Mil as of Mar. 2026. GuruFocus rates SHSE:688137 with a GF Score™ of 62/100 and a GF Value™ of ¥37.73 (Fairly Valued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Suzhou Novoprotein Scientific Co's Research & Development for the three months ended in Mar. 2026 was ¥15.9 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ¥66.7 Mil.

Suzhou Novoprotein Scientific Co  (SHSE:688137) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Suzhou Novoprotein Scientific Co Research & Development Related Terms

Suzhou Novoprotein Scientific Co Research & Development Historical Data

* Premium members only.

The historical data trend for Suzhou Novoprotein Scientific Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzhou Novoprotein Scientific Co Research & Development Chart

Suzhou Novoprotein Scientific Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 34.10 41.10 44.79 49.92 64.06

Suzhou Novoprotein Scientific Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.32 12.78 14.15 23.81 15.93
SHSE:688137
62GF Score
Suzhou Novoprotein Scientific Co Ltd SHSE:688137
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suzhou Novoprotein Scientific Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥66.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥66.7 Mil mean?
Suzhou Novoprotein Scientific Co (SHSE:688137) has a Research & Development of ¥66.7 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Suzhou Novoprotein Scientific Co and its competitors.
Is Suzhou Novoprotein Scientific Co's Research & Development too high?
Suzhou Novoprotein Scientific Co's current Research & Development is ¥66.7 Mil. Overall, Suzhou Novoprotein Scientific Co has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Suzhou Novoprotein Scientific Co's Research & Development compare to VRTX and REGN?
Suzhou Novoprotein Scientific Co's Research & Development of ¥66.7 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Suzhou Novoprotein Scientific Co and its competitors. Suzhou Novoprotein Scientific Co's current Research & Development is ¥66.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Novoprotein Scientific Co stock overvalued right now?
Based on GuruFocus' analysis, Suzhou Novoprotein Scientific Co (SHSE:688137) is currently considered Fairly Valued. The stock's GF Value™ is ¥37.73, compared to a current price of ¥34.76 — trading 7.9% below its estimated fair value. The current Research & Development is ¥66.7 Mil. Suzhou Novoprotein Scientific Co's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Suzhou Novoprotein Scientific Co (SHSE:688137), the current Research & Development is ¥66.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Suzhou Novoprotein Scientific Co (SHSE:688137) Overvalued in 2026?

Based on GuruFocus' analysis, Suzhou Novoprotein Scientific Co stock appears to be undervalued. The current stock price of ¥34.76 is trading 7.9% below its estimated GF Value™ of ¥37.73. GuruFocus considers Suzhou Novoprotein Scientific Co to be Fairly Valued.

Key valuation signals for SHSE:688137:

  • Research & Development: ¥66.7 Mil
  • GF Value™: ¥37.73 vs. price of ¥34.76 (7.9% below fair value)
  • GF Score™: 62/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688137 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Suzhou Novoprotein Scientific Co Business Description

Address No. 228, Yunchuang Road, 3rd & 4th Floor, Wujiang Economic and Technological Development Zone, Jiangsu Province, Suzhou, CHN, 215299
Suzhou Novoprotein Scientific Co Ltd is a high-tech enterprise focusing on recombinant protein application solutions. Its main business is the research and development of target and cytokine proteins, recombinant antibodies, enzymes, and reagents, Production and sales, and providing related technical services.
62GF Score

Get the complete analysis for SHSE:688137

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥34.76
Price
¥37.73
GF Value